tiprankstipranks
Advertisement
Advertisement

Ryan Specialty Launches Empower Program and Share Repurchases

Story Highlights
  • Ryan Specialty launched a multi-year Empower Program to streamline operations, invest in technology and cut costs, targeting $80 million in annual savings by 2029 despite $160 million in restructuring charges through 2028.
  • The company paired this restructuring with a $300 million share repurchase authorization after posting strong 2025 revenue growth but softer net income and margins, emphasizing both operational efficiency and enhanced shareholder returns.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Ryan Specialty Launches Empower Program and Share Repurchases

Claim 30% Off TipRanks

Ryan Specialty Group ( (RYAN) ) has shared an announcement.

On February 10, 2026, Ryan Specialty’s board approved a three-year “Empower Program” restructuring, beginning in the first quarter of 2026, aimed at streamlining brokerage, binding and underwriting operations, scaling data and technology capabilities and improving efficiency across specialties. The initiative, which comprises business platform optimization and changes to compensation and benefits, is expected to be completed by the end of 2028, generate about $80 million in annual savings by 2029 and result in roughly $160 million in pre-tax charges, about 95% of which will require future cash outlays and be treated as special items in reported results.

The board also authorized a share repurchase program of up to $300 million in Class A common stock, adding buybacks to Ryan Specialty’s capital allocation tools and signaling confidence in the firm’s outlook and commitment to enhancing shareholder returns. In tandem with these actions, the company reported fourth-quarter 2025 revenue growth of 13.2% to $751.2 million and full-year 2025 revenue growth of 21.3% to $3.05 billion, supported by 10.1% organic growth and contributions from five acquisitions, even as net income declined year over year and margins compressed amid higher operating expenses.

Management highlighted that 2025 marked the firm’s seventh consecutive year of 20%-plus total revenue growth and 15th straight year of double-digit organic growth, underscoring its continued expansion and market share gains despite industry headwinds. The Empower Program and new repurchase authorization together indicate a dual focus on operational optimization and shareholder value, with implications for near-term earnings volatility due to restructuring charges but potential longer-term margin improvement and accretive capital returns.

The most recent analyst rating on (RYAN) stock is a Hold with a $49.00 price target. To see the full list of analyst forecasts on Ryan Specialty Group stock, see the RYAN Stock Forecast page.

Spark’s Take on RYAN Stock

According to Spark, TipRanks’ AI Analyst, RYAN is a Neutral.

Ryan Specialty Group’s strong revenue growth and strategic investments are key strengths, but high leverage, low profit margins, and valuation concerns weigh on the overall score. Technical indicators suggest bearish momentum, while the earnings call highlights both growth opportunities and margin pressures.

To see Spark’s full report on RYAN stock, click here.

More about Ryan Specialty Group

Ryan Specialty Holdings, Inc., listed on the NYSE under the ticker RYAN, is a leading international specialty insurance firm focused on brokerage, binding authority and underwriting services. The company operates across multiple specialty lines, emphasizing delegated authority platforms and innovative insurance products to serve a diversified base of clients in transitioning insurance markets.

Average Trading Volume: 1,369,494

Technical Sentiment Signal: Sell

Current Market Cap: $11.84B

For detailed information about RYAN stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1